2 results
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Antiplatelet Conversion ... inhibitors during ... syndrome patients (ACS ... #conversion #Clopidogrel ... #prasugrel #pharmacology
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... a maintenance dose ... the timing and dosing ... #conversion #Clopidogrel ... #prasugrel #pharmacology